Starcast
Join the waitlist
Autoimmune Diabetes: The Next Decade | Dr. Tom Elliott
Coming soon to iPhone. Already have it? “Listen in Starcast” takes you straight there.
On this episode
About this episode
About the Episode Some people diagnosed with type 2 diabetes have a slow, autoimmune form of diabetes called LADA, where the immune system attacks the cells that make insulin. Dr. Brendan Byrne and endocrinologist Dr. Tom Elliott explain how antibody testing works, what the newly approved drug teplizumab can and can't do, and why very low doses of Ozempic may help protect insulin-making cells. They also look ahead at the treatments that could arrive in the next five to ten years. About the Guest Dr. Tom Elliott is an endocrinologist at Vancouver General Hospital and a Clinical Associate Professor at the University of British Columbia, where he has been on faculty since 1992. He founded BC…